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Objective: A case series evaluating the acute effects of noninvasive positive pressure ventila-
tion (NPPV) in patients with chronic hypercapnic respiratory failure (HRF) secondary to inter-
stitial lung diseases (ILD).
Patients and methods: Ten patients with ILD were retrospectively evaluated. All had restric-
tive lung function (mean TLC, 47.6 12.6% predicted) and chronic hypercapnic respiratory
failure (mean pHZ 7.39 0.02). Arterial blood gas analysis and lung function were compared
before and after the application of controlled pressure-limited NPPV.
Results: Daytime PaCO2 during spontaneous breathing decreased by 5.4  1.3 mmHg (95%
confidence interval, 4.5e6.3), from 57.7 5.1 mmHg to 52.3 5.9 (p< 0.001); while daytime
PaO2 increased by 3.4 3.3 mmHg (95% confidence interval, 1.0e5.8), from 63.7 3.5 mmHg
to 67.1 3.4 (pZ 0.01); and TLC increased by 3.9 4.5% (95% confidence interval, 0.7e
7.1), from 47.6 12.6% mmHg to 51.5 10.0% (pZ 0.023).
Conclusions: In patients with ILD and chronic HRF controlled NPPV is tolerated and can acutely
improve blood gas levels. Further studies examining the long-term benefits need to be
explored.
ª 2009 Elsevier Ltd. All rights reserved.l, MD, Fachkrankenhaus Cos-
r Pulmonology and Thoracic
Coswig, Germany. Tel./fax:
hkrankenhaus-coswig.de
9 Elsevier Ltd. All rights reservedIntroduction
Interstitial lung diseases (ILD), or diffuse parenchymal lung
disease, may have known or unknown causes. The term
refers to a heterogenous group of non-neoplastic disorders
resulting from damage to lung parenchyma which affect not
only the interstitium, but also the airspaces, peripheral
airways and vessels.1 These chronic diseases are charac-
terised by breathlessness, increasing hypoxia and.
292 D. Koschel et al.hyperventilation. Hypercapnia can occur even in cases of
acute exacerbations (e.g. due to infections, heart failure or
thromboembolism) or in late stages of the diseases because
the lungs become so stiff and the resistance increases to
such a point that the respiratory muscles can no longer
sustain the loads.2
A consensus conference for long-term use of NPPV in
patients with chronic hypercapnic respiratory failure rec-
ommended NPPV in chronic neuromuscular diseases,
thoracic cage disorders, severe stable COPD and nocturnal
hypoventilation from additional disorders such as obesity
hypoventilation syndrome.3 In ILD there are only few data
about NPPV in respiratory failure due to acute exacerba-
tions of idiopathic pulmonary fibrosis4,5 but there are no
reports about the use of NPPV in stable ILD with chronic
hypercapnic respiratory failure. To the best of the authors’
knowledge, this is the first case series about NPPV in
patients with ILD and chronic hypercapnic respiratory
failure.
Materials and methods
Patients
The case records of ten patients with ILD who had been
treated with NPPV between April 2005 and April 2008 (3
years) were retrospectively reviewed. All patients were
referred to our hospital for clinical management. Chronic
hypersensitivity pneumonitis (bird fancier’s lung) was
diagnosed in six patients according to published diagnostic
criteria.6,7 In two patients chronic sarcoidosis was diag-
nosed by clinical and radiological signs and the histological
evidence of non-caseating granulomas obtained by biopsy
through bronchoscopy in lung parenchym and/or medias-
tinal lymph nodes. In a further two patients there was
interstitial lung disease without conclusive entity.
All patients had chronic hypercapnic respiratory failure
(pH> 7.35) when given NPPV and no patients had signs of
acute exacerbation and/or infection.
NPPV
All patients were treated with pressure-limited NPPV in the
assist/control mode. Two types of pressure-cycled venti-
lators were used (VS Integra; Saime; Savigny le Temple,
France and Legendair; Airox; Pau, France). Interfaces
included customized or commercial nasal masks (Comfort
Gel; Respironics; Murrysville, PA, USA) with a chinstrap to
minimize oral leaks, or full-face masks (Ultra Mirage or
Mirage Full Face; ResMed; San Diego, CA, USA). A one-way
circuit with an expiratory valve was used in all patients.
Passive humidification using a heat and moisture exchanger
(Hygrovent S; Medisize bv; Hillegom, the Netherlands) was
provided for all patients. NPPV was introduced as described
in patients with stable COPD8, and inspiratory pressure was
increased until further increases were not tolerated by the
patient. All patients had been receiving long-term oxygen
therapy prior to NPPV treatment and this was not changed
during the NPPV period.
Improvements in blood gas levels during nocturnal NPPV
were verified by blood gas measurements and/ortranscutanous capnography at night while patients were
receiving NPPV.
Data collections and measurements
Pulmonary function test measurements were obtained with
the patients in a sitting position. The forced spirometry
readings were obtained using a pneumotachographic
spirometer and lung volumes were determined using body
plethysmography (Masterlab-Compact Labor; Viasys
Healthcare; Hoechberg, Germany). Pulmonary function
measurements were performed before initiating NPPV and
either during the first visit after the establishment of NPPV
or at the next control visit in the clinic after six to eight
weeks. Blood gas measurements were obtained at rest from
arterialized earlobe during spontaneous breathing (ABL
700; Radiometer; Willich, Germany) before initiation of
NPPV and after stable establishment of NPPV but at least
2 h after cessation of nocturnal NPPV. Inspiratory mouth
occlusion pressures (ZAN100; ZAN Gera¨tetechnik; Ober-
thulba, Germany) were measured during both quiet
breathing (P0.1) and during maximal inspiratory mouth
pressure (Pimax).
Statistical analysis
Statistical analysis was performed using statistical software
SPSS (Version 14.01, SPSS Inc., Chicago, IL, USA). Data are
presented as mean SD or as mean differences with 95%
confidence intervals. After testing for normal distribution
(KolmogoroveSmirnov test), a comparison of measure-
ments before and after treatment with NPPV was per-
formed using the paired t test. Statistical significance was
assumed with a p value below 0.05.
Results
Ten patients with ILD were evaluated (Table 1). The mean
age of the ten patients (nine female, one male) was 60 6
years (range, 52e70 years). Chronic hypersensitivity pneu-
monitis (bird fancier’s lung) was diagnosed in six patients,
chronic sarcoidosis of the lung in two patients, and lung
fibrosis without conclusive entity in a further two patients.
All patients had moderate to severe restrictive lung func-
tion pattern (mean TLCZ 47.6 12.6% predicted) and no
coexisting airflow limitation (FEV1/FVCZ 91.4 3.3).
Inspiratory mouth occlusion pressure was measured in
seven patients before NPPV was started. The inspiratory
mouth occlusion pressure 100 ms after the onset of inspi-
ration during quiet breathing (P0.1) was 3.15 0.8 mmHg,
and during maximal inspiration (Pimax), was
28.8 6.7 mmHg.
In eight patients a transthoracic echocardiography was
performed. In only one patient could a left heart dysfunc-
tion be detected (ejection fraction 35%), but with normal
pulmonary capillary wedge pressure. The estimated right
ventricular systolic pressure in transthoracic echocardiog-
raphy was elevated (RVSP 63.1 21.7 mmHg). Six patients
also underwent right heart catheterization for invasive
measurement of resting hemodynamics. Pulmonary hyper-
tension, defined as a mean pulmonary artery pressure
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NPPV in interstitial lung disease 293(mPAP)> 25 mmHg, was present in five patients (mean
mPAP 31.7 10.2 mmHg).
In all patients a pressure-limited controlled mode of
NPPV was initiated. A mean inspiratory pressure of
28.1 2.5 cm H2O (range, 24e30 cm H2O) was achieved.
The mean respiratory rate was 23.5 3.4 breaths/min
(range, 20e32 breaths/min). Supplemental oxygen was
administered with a mean flow of 2.5 1.4 L/min (range,
1e5 L/min).
The mean body mass index (BMI) was 27.8 5.9 kg/m2
(range, 18e37 kg/m2). Four patients were obese
(BMI 30 kg/m2).
The mean PaO2 during the established long-term
oxygen therapy was 63.7 3.5 mmHg and the mean PaCO2
was 57.7 5.1 mmHg. All patients had chronic hyper-
capnic respiratory failure with pHZ 7.39 0.02. After
stable establishment of controlled pressure-limited NPPV,
blood gas levels during spontaneous breathing and lung
function improved significantly (Table 2). There was
a significant reduction of PaCO2 from 57.7 5.1 mmHg to
52.3 5.9 mmHg (p< 0.001) and a significant increase of
PaO2 from 63.7 3.5 mmHg to 67.1 3.4 mmHg
(pZ 0.011). The TLC improved from 47.6 12.6% pred. to
51.5 10.0% pred. (pZ 0.023).Discussion
The present case series shows for the first time the acute
effects of noninvasive positive pressure ventilation on
blood gas analysis and lung function in ten patients with
chronic hypercapnic respiratory failure in ILD. All patients
had moderate to severe restrictive lung function pattern
(mean TLCZ 47.6 12.6% predicted) and no coexisting
airflow limitation (FEV1/FVCZ 91.4 3.3). All of our
patients were on controlled pressure-limited NPPV with
a mean inspiratory pressure of 28 cm H2O. With this modus
we achieved a significant improvement in blood gas levels
and partially in lung function during spontaneous breathing.
PaCO2 was decreased by a mean of 5.4 mmHg, PaO2
increased by a mean of 3.4 mmHg, and the TLC increased
by a mean of nearly 4% of the predicted value.
Generally, in ILD, despite some acute reasons for
respiratory failure such as infections, heart failure,
thromboembolism or pneumothorax, respiratory failure
occurs commonly, often as a terminal event after a pro-
longed course of illness.9 In hypersensitivity pneumonitis,
a granulomatous form of ILD mostly with an identifiable
cause, a chronic course can progress to pulmonary fibrosis
with respiratory failure10 and is associated with a poor
long-term prognosis.11,12 Sarcoidosis is another chronic
granulomatous interstitial lung disease with two possible
outcomes: in the majority of cases it is a self-limiting
disease, but there is also a possibility of progression to
extensive fibrotic lung disease with terminal respiratory
failure.13
More information exists about respiratory failure in
idopathic pulmonary fibrosis, particularly about the
management of acute respiratory failure (ARF). It was
shown that in mechanically ventilated patients with end-
stage fibrosis due to acute respiratory failure, the elas-
tances and resistances of the respiratory system were
Table 2 Blood gas levels and lung function parameters prior to NPPV and after acute establishment of NPPV in patients with
chronic HRF due to interstitial lung diseases.
Variables Prior NPPV After NPPV Treatment effect 95% confidence interval p value
pH 7.39 0.02 7.42 0.02 0.03 0.01 0.02e0.04 <0.001
PaCO2, mmHg 57.7 5.1 52.3 5.9 5.4 1.3 6.3 to 4.5 <0.001
PaO2, mmHg 63.7 3.5 67.1 3.4 3.4 3.3 1.0e5.8 0.011
HCO3, mmol/L 31.9 1.5 31.7 1.8 0.2 1.4 0.8e1.2 0.662
TLC, % pred. 47.6 12.6 51.5 10.0 3.9 4.5 0.7e7.1 0.023
FVC, % pred. 40.8 15.6 44.3 14.7 3.5 5.2 0.2e7.2 0.064
FEV1, % pred. 44.1 16.1 48.0 15.9 3.9 6.1 0.5e8.3 0.073
FEV1/FVC % 91.4 3.3 92.5 5.8 1.1 3.8 1.7e3.8 0.389
Data are presented as mean SD.
294 D. Koschel et al.significantly altered. These abnormalities in lung
mechanics may be responsible for the onset of
hypercapnia.2
In 2001, three studies were published about the outcome
of patients with idiopathic pulmonary fibrosis and acute
respiratory failure admitted to an intensive care unit.
Saydain et al demonstrated that there was a high failure
rate in 38 patients with ARF even if they needed invasive or
noninvasive mechanical ventilation support.4 In a report
from Blivet et al, 15 patients with idiopathic pulmonary
fibrosis and ARF all needed invasive mechanical ventilation.
In two patients a prior trial of noninvasive ventilation was
done without success. Thirteen patients died in the inten-
sive care unit or shortly thereafter.14 In another case series
all but one of 23 patients with ARF in idopathic pulmonary
fibrosis died while receiving mechanical ventilation. The
survivor successfully received a lung transplant six hours
after initiating mechanical ventilation.15 In a review about
patients with IPF ventilated in intensive care it was
summarized that the outcome in the intensive care unit is
very poor and mechanical ventilation is mostly futile.
Postsurgical patients with respiratory failure have a better
survival as the precipitating condition is likely reversible.16
This very poor prognosis was not only in patients with ido-
pathic pulmonary fibrosis. Of 20 patients with severe ARF, 6
had pulmonary fibrosis associated with collagen vascular
diseases. All but 3 required mechanical ventilation with
a 100% mortality because of refractory hypoxemic respira-
tory failure.17
In severe cases of chronic pigeon breeder’s lung,
a hypercapnic respiratory failure is associated with
pulmonary hypertension.18 Six of our ten patients had
chronic bird fancier’s lung. Five of these six patients had
pulmonary hypertension either detected by transthoracic
echocardiography or right heart catheterization.
Mechanical ventilation can be a bridge to lung trans-
plantation in end-stage lung disease. There are some case
reports about NPPV as a bridge to lung transplantation in
patients with CF, COPD or sarcoidosis.19 In a retrospective
study by Madden et al about NPPV in 113 patients with CF,
noninvasive ventilation failed to correct hypercapnia but it
was still useful for ‘‘bridging the gap’’ between respiratory
failure and lung transplant.20 Two of our patients (no. 2
and 8) were listed for lung transplants. Patient no. 2 died
while awaiting a lung transplant due to pulmonary infec-
tion with sepsis, patient no. 8 is still awaiting their
transplant.Some important limitations of our investigation should
be noted. The small subject numbers and the single-center,
retrospective nature of the design limit our results,
particularly the statistical analysis. Since there was no
long-term follow-up, it is unknown how long the patients
will continue to use NPPV. However, the aim of this study
was to test the principle of NPPV in patients with intersti-
tial lung diseases and chronic HRF and further prospective,
randomized controlled trials will be needed to confirm our
results.
In summary, there are no reports about noninvasive
ventilation in interstitial lung diseases such as idiopathic
lung fibrosis, chronic hypersensitivity pneumonitis or
chronic pulmonary sarcoidosis with chronic hypercapnic
respiratory failure in the recent literature. We have
demonstrated that noninvasive positive pressure ventila-
tion can acutely improve chronic hypercapnic respiratory
failure in patients with interstitial lung diseases. Using
controlled pressure-limited NPPV with a mean inspiration
pressure of 28 cm H2O and a mean respiratory rate of
23.5 breaths/min a significant decrease of PaCO2 and
increase of PaO2 could be achieved.
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